Detalles de la búsqueda
1.
Optimization of a dihydropyrrolopyrazole series of transforming growth factor-beta type I receptor kinase domain inhibitors: discovery of an orally bioavailable transforming growth factor-beta receptor type I inhibitor as antitumor agent.
J Med Chem
; 51(7): 2302-6, 2008 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-18314943
2.
Dihydropyrrolopyrazole transforming growth factor-beta type I receptor kinase domain inhibitors: a novel benzimidazole series with selectivity versus transforming growth factor-beta type II receptor kinase and mixed lineage kinase-7.
J Med Chem
; 49(6): 2138-42, 2006 Mar 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-16539403
Resultados
1 -
2
de 2
1
Próxima >
>>